Cinobufagin Suppresses The Characteristics Of Osteosarcoma Cancer Cells By Inhibiting The IL-6-OPN-STAT3 Pathway

BACKGROUND: Current clinical treatments for osteosarcoma are limited by disease recurrence and primary or secondary chemoresistance. Cancer stem-like cells have been proposed to facilitate the initiation, progression, recurrence and chemoresistance of osteosarcoma. Furthermore, previous studies have...

Descripción completa

Detalles Bibliográficos
Autores principales: Zhang, Chuan, Ma, Kun, Li, Wu-Yin
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove 2019
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6900468/
https://www.ncbi.nlm.nih.gov/pubmed/31824138
http://dx.doi.org/10.2147/DDDT.S224312

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6900468/
https://www.ncbi.nlm.nih.gov/pubmed/31824138
http://dx.doi.org/10.2147/DDDT.S224312

Ejemplares similares